European Investor
23 Jul 2025, 10:59
Merck Selects Veeva Vault CRM to Support Major Launch Period
Veeva Systems (NYSE: VEEV) announced on July 21, 2025, that Merck (NYSE: MRK) has committed to adopting Veeva Vault CRM as its commercial execution platform. This move supports Merck’s entry into one of the most significant launch phases in its history, spanning multiple therapeutic areas and treatment modalities.
The partnership expands Merck’s longstanding relationship with Veeva, aiming to boost global commercial capabilities through Vault CRM’s personal and digital engagement tools and compliance-tailored features. Merck’s EVP and CIO Dave Williams highlighted the role of Vault CRM in enhancing customer success and execution.
Vault CRM is part of the broader Vault CRM Suite, designed for the life sciences industry’s complex regional and compliance needs.
Veeva Systems (NYSE: VEEV) announced on July 21, 2025, that Merck (NYSE: MRK) has committed to adopting Veeva Vault CRM as its commercial execution platform. This move supports Merck’s entry into one of the most significant launch phases in its history, spanning multiple therapeutic areas and treatment modalities.
The partnership expands Merck’s longstanding relationship with Veeva, aiming to boost global commercial capabilities through Vault CRM’s personal and digital engagement tools and compliance-tailored features. Merck’s EVP and CIO Dave Williams highlighted the role of Vault CRM in enhancing customer success and execution.
Vault CRM is part of the broader Vault CRM Suite, designed for the life sciences industry’s complex regional and compliance needs.